Literature DB >> 22024826

Lack of antimicrobial resistance in Yersinia pestis isolates from 17 countries in the Americas, Africa, and Asia.

Sandra K Urich1, Linda Chalcraft, Martin E Schriefer, Brook M Yockey, Jeannine M Petersen.   

Abstract

Yersinia pestis is the causative agent of plague, a fulminant disease that is often fatal without antimicrobial treatment. Plasmid (IncA/C)-mediated multidrug resistance in Y. pestis was reported in 1995 in Madagascar and has generated considerable public health concern, most recently because of the identification of IncA/C multidrug-resistant plasmids in other zoonotic pathogens. Here, we demonstrate no resistance in 392 Y. pestis isolates from 17 countries to eight antimicrobials used for treatment or prophylaxis of plague.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22024826      PMCID: PMC3256048          DOI: 10.1128/AAC.05043-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Double infection of the rat fleas X. cheopis and N. fasciatus with Pasteurella and Salmonella.

Authors:  C R ESKEY; F M PRINCE; F B FULLER
Journal:  Public Health Rep       Date:  1951-10-12       Impact factor: 2.792

Review 2.  Resistance of Yersinia pestis to antimicrobial agents.

Authors:  Marc Galimand; Elisabeth Carniel; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

3.  Bacterial communities of Bartonella-positive fleas: diversity and community assembly patterns.

Authors:  Ryan T Jones; Katherine F McCormick; Andrew P Martin
Journal:  Appl Environ Microbiol       Date:  2008-01-18       Impact factor: 4.792

4.  Multidrug resistance in Yersinia pestis mediated by a transferable plasmid.

Authors:  M Galimand; A Guiyoule; G Gerbaud; B Rasoamanana; S Chanteau; E Carniel; P Courvalin
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

Review 5.  Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Authors:  T V Inglesby; D T Dennis; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; A M Friedlander; J Hauer; J F Koerner; M Layton; J McDade; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; M Schoch-Spana; K Tonat
Journal:  JAMA       Date:  2000-05-03       Impact factor: 56.272

6.  Efficacy of the latest fluoroquinolones against experimental Yersinia pestis.

Authors:  J Steward; M S Lever; P Russell; R J Beedham; A J Stagg; R R Taylor; T J G Brooks
Journal:  Int J Antimicrob Agents       Date:  2004-12       Impact factor: 5.283

Review 7.  Common ground for the control of multidrug-resistant Salmonella in ground beef.

Authors:  Elizabeth A Talbot; Elizabeth R Gagnon; Jesse Greenblatt
Journal:  Clin Infect Dis       Date:  2006-04-13       Impact factor: 9.079

8.  blaCMY-2-positive IncA/C plasmids from Escherichia coli and Salmonella enterica are a distinct component of a larger lineage of plasmids.

Authors:  Douglas R Call; Randall S Singer; Da Meng; Shira L Broschat; Lisa H Orfe; Janet M Anderson; David R Herndon; Lowell S Kappmeyer; Joshua B Daniels; Thomas E Besser
Journal:  Antimicrob Agents Chemother       Date:  2009-11-30       Impact factor: 5.191

Review 9.  Studies of vector competency and efficiency of North American fleas for Yersinia pestis: state of the field and future research needs.

Authors:  Rebecca J Eisen; Lars Eisen; Kenneth L Gage
Journal:  J Med Entomol       Date:  2009-07       Impact factor: 2.278

Review 10.  The evolution of flea-borne transmission in Yersinia pestis.

Authors:  B Joseph Hinnebusch
Journal:  Curr Issues Mol Biol       Date:  2005-07       Impact factor: 2.081

View more
  8 in total

1.  In vitro antibiotic susceptibilities of Yersinia pestis determined by broth microdilution following CLSI methods.

Authors:  Henry S Heine; Jeremy Hershfield; Charles Marchand; Lynda Miller; Stephanie Halasohoris; Bret K Purcell; Patricia L Worsham
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

2.  Rapid Antimicrobial Susceptibility Testing of Bacillus anthracis, Yersinia pestis, and Burkholderia pseudomallei by Use of Laser Light Scattering Technology.

Authors:  Julia V Bugrysheva; Christine Lascols; David Sue; Linda M Weigel
Journal:  J Clin Microbiol       Date:  2016-03-16       Impact factor: 5.948

3.  Yersinia pestis antibiotic resistance: a systematic review.

Authors:  Chen Lei; Suresh Kumar
Journal:  Osong Public Health Res Perspect       Date:  2022-02-18

Review 4.  Plague gives surprises in the first decade of the 21st century in the United States and worldwide.

Authors:  Thomas Butler
Journal:  Am J Trop Med Hyg       Date:  2013-09-16       Impact factor: 2.345

5.  Rapid Detection of Genetic Engineering, Structural Variation, and Antimicrobial Resistance Markers in Bacterial Biothreat Pathogens by Nanopore Sequencing.

Authors:  Amy S Gargis; Blake Cherney; Andrew B Conley; Heather P McLaughlin; David Sue
Journal:  Sci Rep       Date:  2019-09-18       Impact factor: 4.379

6.  A novel mechanism of streptomycin resistance in Yersinia pestis: Mutation in the rpsL gene.

Authors:  Ruixia Dai; Jian He; Xi Zha; Yiting Wang; Xuefei Zhang; He Gao; Xiaoyan Yang; Juan Li; Youquan Xin; Yumeng Wang; Sheng Li; Juan Jin; Qi Zhang; Jixiang Bai; Yao Peng; Hailian Wu; Qingwen Zhang; Baiqing Wei; Jianguo Xu; Wei Li
Journal:  PLoS Negl Trop Dis       Date:  2021-04-22

Review 7.  Antibiotic Therapy of Plague: A Review.

Authors:  Florent Sebbane; Nadine Lemaître
Journal:  Biomolecules       Date:  2021-05-12

8.  Transmission of Antimicrobial Resistant Yersinia pestis During a Pneumonic Plague Outbreak.

Authors:  Voahangy Andrianaivoarimanana; David M Wagner; Dawn N Birdsell; Birgit Nikolay; Faniry Rakotoarimanana; Lovasoa N Randriantseheno; Amy J Vogler; Jason W Sahl; Carina M Hall; Nawarat Somprasong; Simon Cauchemez; Herbert P Schweizer; Harimahefa Razafimandimby; Christophe Rogier; Minoarisoa Rajerison
Journal:  Clin Infect Dis       Date:  2022-03-01       Impact factor: 9.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.